
Captain T Cell
Operator of a T-cell therapy firm intended for drug discovery. The company develops efficacy-enhanced therapies against solid tumors not addressed by existing treatments, enabling patients to treat th...
Valuation
$0
Share Price
N/A
Total Raised
$9.2M
Last Round
N/A